Diabetes Data Articles & Analysis

4 news found

Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors

Prior to this, Amit established the Digital Health function at Medtronic Diabetes, building the data science team to drive business and product strategy. ...

Dec. 3, 2022

ByBodyport Inc.

Microbion Corporation Receives up to $2.1 million in Funding Support from the US Navy in Partnership with CUBRC, Inc. to Advance Topical Pravibismane

The evaluation and treatment of diabetic foot ulcers and diabetic foot infections. Foot & Ankle Orthopaedics. 2018;3:3. doi:10.1177/2473011418788864 2.Sundararajan PP, Porter BM, Grant KA, et al. ...

Jun. 7, 2022

ByMicrobion Corporation

New data from finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D independent of baseline therapy

Exploratory analysis of the FIGARO-DKD study with finerenone, a non-steroidal, selective mineralocorticoid receptor antagonist, indicated a reduction in renal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), as seen in the FIDELIO-DKD study Analysis of the FIDELIO-DKD study highlighted that early reduction of urine albumin-to-creatinine ratio ...

Nov. 8, 2021

ByBayer AG

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

Preclinical research and compassionate use data indicate 18-21 mg/kg will be the target effective dose for the expansion phase of the study. ...

Jul. 13, 2021

ByAVM Biotechnology

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you